eGenesis Gene Editing CRISPR-Cas 9 gene editing company focused on editing the pig genome for xenotransplantation http://www.egenesisbio.com/ Press Releases eGenesis Announces $100M Series B Financing Nov 7, 2019 eGenesis Appoints Ariel Jasie as Chief Business Officer and General Counsel Jun 11, 2019 eGenesis Appoints Industry Veteran Paul Sekhri as President and Chief Executive Officer Jan 17, 2019 eGenesis Appoints William Westlin, Ph.D., as Executive Vice President of Research & Development Dec 15, 2018 eGenesis Announces Global Collaboration with Qihan Biotech to Address Global Shortage of Organs with Xenotransplantation Aug 1, 2018 eGenesis Study Addressing Cross-Species Viral Transmission Concern in Xenotransplantation Published in Science Aug 10, 2017 eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation Mar 16, 2017 eGenesis Co-Founder Luhan Yang Named Young Global Leader by World Economic Forum Mar 15, 2017 Press Coverage Forbes | Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself May 15, 2019 UMass Boston News | UMass Boston’s Venture Development Center Hits $1 Billion Funding Milestone May 7, 2019 Using animal organs in humans: ‘It’s just a question of when’ Apr 3, 2019 MIT Technology Review | Genome engineers made more than 13,000 CRISPR edits in a single cell Mar 26, 2019 Bloomberg Radio | Julie Sunderland, CEO at eGenesis, explains a gene editing platform for the development of human-compatible organs, tissues and cells Jan 9, 2019 BioCentury: BayHelix launches Gene-Editing Task Force Dec 12, 2018
eGenesis Appoints William Westlin, Ph.D., as Executive Vice President of Research & Development Dec 15, 2018
eGenesis Announces Global Collaboration with Qihan Biotech to Address Global Shortage of Organs with Xenotransplantation Aug 1, 2018
eGenesis Study Addressing Cross-Species Viral Transmission Concern in Xenotransplantation Published in Science Aug 10, 2017
eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation Mar 16, 2017
Forbes | Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself May 15, 2019
UMass Boston News | UMass Boston’s Venture Development Center Hits $1 Billion Funding Milestone May 7, 2019
MIT Technology Review | Genome engineers made more than 13,000 CRISPR edits in a single cell Mar 26, 2019
Bloomberg Radio | Julie Sunderland, CEO at eGenesis, explains a gene editing platform for the development of human-compatible organs, tissues and cells Jan 9, 2019
